Complement C4
Immunsystem & EntzündungZuletzt geprüft: 7. April 2026. Quellenansatz: Standardkontext zur Laborinterpretation, allgemeine medizinische Referenzmaterialien sowie öffentliche Gesundheits- oder klinische Leitlinien, sofern relevant.
Was ist Complement C4?
Complement C4 is a glycoprotein and essential component of the classical and lectin complement activation pathways. It is encoded by two genes, C4A and C4B, located within the major histocompatibility complex (MHC) on chromosome 6p21. The number of C4 gene copies varies widely in the population—individuals may carry 2 to 8 copies total—which accounts for the broad normal range of C4 protein levels. When the classical pathway is activated (typically by antigen-antibody immune complexes binding C1q), C1s cleaves C4 into C4a (a small anaphylatoxin) and C4b, which binds covalently to the target surface and participates in forming the C3 convertase (C4b2a) that amplifies the complement cascade.
C4 is an important clinical biomarker primarily in two contexts: monitoring autoimmune disease activity (especially SLE) and diagnosing hereditary angioedema (HAE). In active SLE, immune complexes chronically consume classical pathway components, leading to decreased C4 and C3. Importantly, C4 is often the first complement component to decline in a lupus flare, sometimes before C3 drops. In hereditary angioedema types I and II, C4 is characteristically low even between attacks due to chronic unregulated C1 activation from C1-inhibitor deficiency, making C4 an excellent screening test for this condition.
Warum der Wert wichtig ist
Low C4 is among the earliest laboratory indicators of a lupus flare, often declining before clinical worsening or C3 changes. Serial C4 monitoring, combined with C3 and anti-dsDNA levels, forms the cornerstone of lupus activity surveillance. C4 is also the first-line screening test for hereditary angioedema—a potentially life-threatening condition causing recurrent episodes of swelling in the face, extremities, gastrointestinal tract, and airway. A normal C4 level between attacks effectively excludes types I and II HAE. Additionally, low C4 due to genetic C4 null alleles (C4A or C4B deficiency) is itself a risk factor for developing SLE, linking C4 to both disease susceptibility and disease monitoring.
Normale Referenzbereiche
| Gruppe | Bereich | Einheit |
|---|---|---|
| Adults | 10–40 | mg/dL |
| Children | 10–40 | mg/dL |
| Newborns | 6–30 | mg/dL |
Referenzbereiche können je nach Labor variieren. Vergleichen Sie Ihre Ergebnisse immer mit den Bereichen Ihres Testlabors.
Was hohe C4-Werte bedeuten
Häufige Ursachen
- Acute phase response (C4 is a mild acute phase reactant)
- Chronic inflammation
- Malignancy (some cases)
- Corticosteroid therapy
Mögliche Symptome
- Elevated C4 does not cause specific symptoms
- Symptoms relate to the underlying inflammatory condition
Was zu tun ist: Elevated C4 is typically a nonspecific finding reflecting acute phase response and rarely requires specific investigation. It may be seen during infections, after surgery, or during corticosteroid therapy. Address the underlying condition as appropriate. Mild elevations do not have established clinical significance as an independent finding.
Was niedrige C4-Werte bedeuten
Häufige Ursachen
- Active systemic lupus erythematosus (classical pathway consumption)
- Hereditary angioedema types I and II (chronic C1-inhibitor deficiency)
- Genetic C4 null alleles (partial C4A or C4B deficiency—common, affecting ~25% of population)
- Cryoglobulinemia
- Immune complex-mediated glomerulonephritis
- Serum sickness
- Severe liver disease (decreased synthesis)
- Bacterial endocarditis (immune complex formation)
Mögliche Symptome
- In lupus: joint pain, fatigue, rash, fever, kidney dysfunction
- In hereditary angioedema: recurrent episodes of facial, limb, abdominal, or laryngeal swelling without urticaria
- Recurrent infections in severe complement deficiency
Was zu tun ist: The clinical context is essential. In known or suspected SLE, low C4 (especially if declining) should prompt assessment for disease flare with anti-dsDNA, urinalysis, and clinical evaluation; immunosuppressive therapy may need escalation. If hereditary angioedema is suspected, check C1-inhibitor level and function, and C1q level. Persistently low C4 without active autoimmune disease may reflect genetic C4 null alleles—these can be confirmed by C4 gene copy number analysis and are associated with increased SLE susceptibility. Genetic C4 deficiency warrants baseline rheumatologic evaluation.
Wann wird ein C4-Test empfohlen?
- When monitoring SLE disease activity (in combination with C3 and anti-dsDNA)
- When hereditary angioedema is suspected (recurrent angioedema without urticaria)
- As part of the workup for suspected immune complex disease or glomerulonephritis
- When evaluating for complement deficiency in recurrent infections
- When cryoglobulinemia or endocarditis-related immune complex disease is considered
Häufig gestellte Fragen
Verwandte Biomarker
Quellen- und Prüfungsansatz
Biomarker-Glossarseiten sind erklärende Bildungsinhalte und sollten immer zusammen mit den Referenzbereichen und Kommentaren Ihres Labors sowie Ihrer Ärztin oder Ihres Arztes interpretiert werden. Mehr zu unseren redaktionellen Standards und unserem Prüfprozess finden Sie in unserer Redaktionsrichtlinie und Prüfprozess für Inhalte.
Möchten Sie Ihre C4-Werte analysieren lassen?
Laden Sie Ihre Laborwerte hoch und erhalten Sie sofort eine KI-gestützte Einordnung aller Biomarker.
Laborwerte hochladen →Medizinischer Hinweis: Diese Informationen dienen nur Bildungszwecken und ersetzen keine professionelle medizinische Beratung, Diagnose oder Behandlung. Referenzbereiche können zwischen Laboren variieren. Besprechen Sie die Interpretation Ihrer konkreten Testergebnisse immer mit Ihrer medizinischen Fachperson.